Cargando…

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer

Durvalumab is an immune checkpoint inhibitor that blocks PD‐L1. Unlike cytotoxic chemotherapy or molecularly targeted agents, immune checkpoint inhibitors occasionally present distinct response patterns, including radiologic pseudoprogression (initial tumor enlargement with subsequent tumor regressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Young, Park, Inkeun, Kim, Young Saing, Ahn, Hee Kyung, Lee, Hee Young, Kim, Jeong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449229/ https://www.ncbi.nlm.nih.gov/pubmed/30734514 http://dx.doi.org/10.1111/1759-7714.12994

Ejemplares similares

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
por: Sweis, Randy F., et al.
Publicado: (2018)

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2016)

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
por: Kim, Eun Young, et al.
Publicado: (2016)

Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma
por: Alt, Marie, et al.
Publicado: (2023)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer
por: Hayakawa, Nozomi, et al.
Publicado: (2022)

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
por: Park, Inkeun, et al.
Publicado: (2016)

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
por: Kim, Young Saing, et al.
Publicado: (2018)

Metastatic Pleural Effusion: An Unusual Presentation of Urothelial Bladder Carcinoma
por: Javed, Isma N, et al.
Publicado: (2019)

A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract
por: Sarfaty, Michal, et al.
Publicado: (2020)

Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis
por: Park, Joo-Hwan, et al.
Publicado: (2022)

Atypical Radiological Manifestation of Pulmonary Metastatic Calcification
por: Kang, Eun Hae, et al.
Publicado: (2008)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
por: Woo, Hyun Sun, et al.
Publicado: (2015)

An unusual ultrasonographic manifestation of a fetal Ebstein anomaly
por: Cha, Min-Young, et al.
Publicado: (2014)

Durvalumab for urothelial carcinoma, non-small cell lung cancer
Publicado: (2019)

Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea
por: Yoon, Jee Hee, et al.
Publicado: (2020)

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
por: Joshi, Monika, et al.
Publicado: (2023)

Pseudoprogression or unexpected favorable response to third-line therapy: a challenging metastatic bladder cancer case
por: Soares, Adriana, et al.
Publicado: (2020)

Unusual Radiologic Findings and Pathologic Growth Patterns on Choroid Plexus Papillomas
por: Kim, Tae-Wan, et al.
Publicado: (2012)

An unusual radiologic manifestation of hypersensitivity pneumonia
por: Toso, Seema, et al.
Publicado: (2017)

Unusual Duodenal Ulcer: Metastatic Urothelial Carcinoma of the Renal Pelvis
por: Won, Yoo Dong, et al.
Publicado: (2023)

Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer
por: Lee, Jongsoo, et al.
Publicado: (2021)

Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer
por: Ahn, Jinwoo, et al.
Publicado: (2016)

The Utility of Fluorescence In Situ Hybridization for Detection of Bladder Urothelial Carcinoma in Routine Clinical Practice
por: Kwak, Kyung Won, et al.
Publicado: (2009)

Urothelial carcinoma of the bladder with asynchronous metastases to both testes
por: Kiely, Gemma, et al.
Publicado: (2013)

Histologic subtypes are not associated with the presence of sarcopenia in lung cancer
por: Kim, Chang Rae, et al.
Publicado: (2018)

Incidence of Immune-Mediated Pseudoprogression of Lymphoma Treated with Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
por: Lee, Amy Junghyun, et al.
Publicado: (2021)

An unusual case of asymptomatic non-urothelial bladder tumour
por: Ching, Daniel, et al.
Publicado: (2016)

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
por: Baek, Min Young, et al.
Publicado: (2018)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Concurrent Bladder Lymphoma and Bladder Cancer Presenting as Metastatic Bladder Cancer
por: Kim, Jae Heon, et al.
Publicado: (2012)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer
por: Huang, Weiwei, et al.
Publicado: (2020)

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
por: Kim, Young Saing, et al.
Publicado: (2016)

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07
por: Kim, Miso, et al.
Publicado: (2020)

An unusual presentation of metastatic disease: Cutaneous metastases from pulmonary adenocarcinoma manifesting as widespread plaques
por: Brown, Danielle Nicole, et al.
Publicado: (2015)

Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
por: Kim, Donghyun, et al.
Publicado: (2020)

Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas
por: Kim, Yoo-Na, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3nkqdje7t5l19s63j1pjeqe57t